Georg Bauer Selected Research

nitric oxide dioxygenase

3/2015	Direct and indirect inactivation of tumor cell protective catalase by salicylic acid and anthocyanidins reactivates intercellular ROS signaling and allows for synergistic effects.
10/2014	Synergistic effects between catalase inhibitors and modulators of nitric oxide metabolism on tumor cell apoptosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Georg Bauer Research Topics

Disease

27	Neoplasms (Cancer) 10/2021 - 09/2002
6	Infections 01/2022 - 09/2012
5	Carcinogenesis 01/2017 - 07/2012
4	COVID-19 01/2022 - 10/2020
2	Carcinoma (Carcinomatosis) 10/2021 - 06/2010
1	Virus Diseases (Viral Diseases) 01/2022
1	Coronavirus Infections 01/2022
1	Inflammation (Inflammations) 01/2014
1	Skin Neoplasms (Skin Cancer) 01/2014
1	Tics (Tic) 02/2011
1	Ewing Sarcoma (Sarcoma, Ewing) 06/2010
1	Astrocytoma (Pilocytic Astrocytoma) 05/2009
1	Epstein-Barr Virus Infections 10/2006

Drug/Important Bio-Agent (IBA)

25	CatalaseIBA 10/2021 - 11/2009
13	Peroxynitrous Acid (Peroxynitrite)IBA 10/2021 - 06/2010
11	Singlet OxygenIBA 01/2019 - 07/2012
9	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2017 - 11/2009
7	Superoxides (Superoxide)IBA 01/2017 - 11/2009
6	Immunoglobulin G (IgG)IBA 01/2022 - 10/2006
6	Oxygen (Dioxygen)IBA 10/2021 - 09/2002
5	NitrogenIBA 10/2021 - 09/2002
5	Superoxide DismutaseIBA 01/2018 - 09/2013
4	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2021 - 06/2010
4	AnionsIBA 01/2017 - 09/2013
4	EnzymesIBA 11/2016 - 09/2013
3	NADP (NADPH)IBA 10/2021 - 01/2017
3	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 01/2019 - 11/2009
3	NitritesIBA 01/2019 - 01/2018
3	Small Interfering RNA (siRNA)IBA 01/2017 - 06/2010
3	Reactive Nitrogen SpeciesIBA 01/2017 - 11/2016
3	Neutralizing AntibodiesIBA 12/2015 - 10/2014
2	NucleoproteinsIBA 01/2022 - 12/2021
2	AntigensIBA 01/2022 - 07/2014
2	Glutathione (Reduced Glutathione)IBA 10/2021 - 10/2019
2	Proteins (Proteins, Gene)FDA Link 01/2018 - 01/2014
2	Nitric Oxide Synthase (NO Synthase)IBA 01/2018 - 10/2014
2	Salicylic Acid (2 Hydroxybenzoic Acid)FDA LinkGeneric 03/2015 - 10/2014
2	nitric oxide dioxygenaseIBA 03/2015 - 10/2014
2	DNA (Deoxyribonucleic Acid)IBA 01/2014 - 05/2009
1	mRNA VaccinesIBA 12/2021
1	Messenger RNA (mRNA)IBA 12/2021
1	Aquaporins (Water Channels)IBA 10/2021
1	Immunoglobulin M (IgM)IBA 01/2021
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 10/2020
1	fas Receptor (CD95 Antigen)IBA 01/2018
1	Peroxidase (Myeloperoxidase)IBA 01/2018
1	Single-Domain AntibodiesIBA 11/2016
1	TransglutaminasesIBA 12/2015
1	4-hydroxy-2-nonenal (4-hydroxynonenal)IBA 04/2015
1	ProdrugsIBA 03/2015
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 03/2015
1	Anthocyanins (Anthocyanin)IBA 03/2015
1	InterferonsIBA 10/2014
1	Methyldopa (Aldomet)FDA LinkGeneric 10/2014
1	Arginine (L-Arginine)FDA Link 10/2014
1	ArginaseIBA 10/2014
1	Cytotoxins (Cytolysins)IBA 07/2014
1	AntioxidantsIBA 07/2014
1	SulfurIBA 01/2014
1	LipidsIBA 01/2014
1	Environmental Pollutants (Pollutants, Environmental)IBA 01/2014
1	CarbonIBA 01/2014
1	Oxidants (Oxidizing Agents)IBA 01/2014
1	AntibodiesIBA 09/2012
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 02/2011
1	Monoclonal AntibodiesIBA 06/2010
1	Hydroxyl RadicalIBA 11/2009
1	IronIBA 11/2009
1	Death Domain ReceptorsIBA 05/2009

Therapy/Procedure

6	Therapeutics 01/2018 - 11/2009
1	Aftercare (After-Treatment) 01/2019